Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota

Research output: Contribution to journalArticlepeer-review

Standard Standard

Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. / Zhu, Yijun; Jameson, Eleanor; Crosatti, Marialuisa et al.
In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, No. 11, 18.03.2014, p. 4268-73.

Research output: Contribution to journalArticlepeer-review

HarvardHarvard

Zhu, Y, Jameson, E, Crosatti, M, Schäfer, H, Rajakumar, K, Bugg, TDH & Chen, Y 2014, 'Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota', Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 11, pp. 4268-73. https://doi.org/10.1073/pnas.1316569111

APA

Zhu, Y., Jameson, E., Crosatti, M., Schäfer, H., Rajakumar, K., Bugg, T. D. H., & Chen, Y. (2014). Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proceedings of the National Academy of Sciences of the United States of America, 111(11), 4268-73. https://doi.org/10.1073/pnas.1316569111

CBE

Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, Chen Y. 2014. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proceedings of the National Academy of Sciences of the United States of America. 111(11):4268-73. https://doi.org/10.1073/pnas.1316569111

MLA

Zhu, Yijun et al. "Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota". Proceedings of the National Academy of Sciences of the United States of America. 2014, 111(11). 4268-73. https://doi.org/10.1073/pnas.1316569111

VancouverVancouver

Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proceedings of the National Academy of Sciences of the United States of America. 2014 Mar 18;111(11):4268-73. Epub 2014 Mar 3. doi: 10.1073/pnas.1316569111

Author

Zhu, Yijun ; Jameson, Eleanor ; Crosatti, Marialuisa et al. / Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. In: Proceedings of the National Academy of Sciences of the United States of America. 2014 ; Vol. 111, No. 11. pp. 4268-73.

RIS

TY - JOUR

T1 - Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota

AU - Zhu, Yijun

AU - Jameson, Eleanor

AU - Crosatti, Marialuisa

AU - Schäfer, Hendrik

AU - Rajakumar, Kumar

AU - Bugg, Timothy D H

AU - Chen, Yin

PY - 2014/3/18

Y1 - 2014/3/18

N2 - Dietary intake of L-carnitine can promote cardiovascular diseases in humans through microbial production of trimethylamine (TMA) and its subsequent oxidation to trimethylamine N-oxide by hepatic flavin-containing monooxygenases. Although our microbiota are responsible for TMA formation from carnitine, the underpinning molecular and biochemical mechanisms remain unclear. In this study, using bioinformatics approaches, we first identified a two-component Rieske-type oxygenase/reductase (CntAB) and associated gene cluster proposed to be involved in carnitine metabolism in representative genomes of the human microbiota. CntA belongs to a group of previously uncharacterized Rieske-type proteins and has an unusual "bridging" glutamate but not the aspartate residue, which is believed to facilitate intersubunit electron transfer between the Rieske center and the catalytic mononuclear iron center. Using Acinetobacter baumannii as the model, we then demonstrate that cntAB is essential in carnitine degradation to TMA. Heterologous overexpression of cntAB enables Escherichia coli to produce TMA, confirming that these genes are sufficient in TMA formation. Site-directed mutagenesis experiments have confirmed that this unusual "bridging glutamate" residue in CntA is essential in catalysis and neither mutant (E205D, E205A) is able to produce TMA. Taken together, the data in our study reveal the molecular and biochemical mechanisms underpinning carnitine metabolism to TMA in human microbiota and assign the role of this novel group of Rieske-type proteins in microbial carnitine metabolism.

AB - Dietary intake of L-carnitine can promote cardiovascular diseases in humans through microbial production of trimethylamine (TMA) and its subsequent oxidation to trimethylamine N-oxide by hepatic flavin-containing monooxygenases. Although our microbiota are responsible for TMA formation from carnitine, the underpinning molecular and biochemical mechanisms remain unclear. In this study, using bioinformatics approaches, we first identified a two-component Rieske-type oxygenase/reductase (CntAB) and associated gene cluster proposed to be involved in carnitine metabolism in representative genomes of the human microbiota. CntA belongs to a group of previously uncharacterized Rieske-type proteins and has an unusual "bridging" glutamate but not the aspartate residue, which is believed to facilitate intersubunit electron transfer between the Rieske center and the catalytic mononuclear iron center. Using Acinetobacter baumannii as the model, we then demonstrate that cntAB is essential in carnitine degradation to TMA. Heterologous overexpression of cntAB enables Escherichia coli to produce TMA, confirming that these genes are sufficient in TMA formation. Site-directed mutagenesis experiments have confirmed that this unusual "bridging glutamate" residue in CntA is essential in catalysis and neither mutant (E205D, E205A) is able to produce TMA. Taken together, the data in our study reveal the molecular and biochemical mechanisms underpinning carnitine metabolism to TMA in human microbiota and assign the role of this novel group of Rieske-type proteins in microbial carnitine metabolism.

KW - Acinetobacter baumannii/metabolism

KW - Carnitine/metabolism

KW - Chromatography, Ion Exchange

KW - Computational Biology

KW - Escherichia coli

KW - Humans

KW - Methylamines/metabolism

KW - Microbiota/genetics

KW - Mutagenesis, Site-Directed

KW - Oxidoreductases/metabolism

KW - Oxygenases/metabolism

KW - Spectrophotometry, Ultraviolet

U2 - 10.1073/pnas.1316569111

DO - 10.1073/pnas.1316569111

M3 - Article

C2 - 24591617

VL - 111

SP - 4268

EP - 4273

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 11

ER -